This conference jointly organised between the Human Genome Organisation (HUGO) and the International Association of Breast Cancer Research (IABCR) focuses on the intersection of Genomics , Biology, and Breast Cancer Treatment.
Dramatic advances in our understanding of mammary gland development, breast cancer biology, and the genetics of cancer susceptibility have been propelled by genomic strategies and databases. We have redefined cancer classification, revealed the precise contours of estrogen receptor signaling, and identified the mammary gland stem cell. These fundamental advances are now converging to make an impact on the treatment of the disease. In this meeting, we will explore how we arrived to this point, and where we will be going to personalize breast cancer prevention and therapy. This conference will be relevant to clinicians, and researchers who wish to explore the extension of their work into this translational interface. In recognition of this, we will host also educational sessions that will expose basic scientists to clinical breast cancer treatment, and clinicians to the fundamental breast cancer research.
In Singapore, we are working directly at the nexus of these three streams of clinical and basic sciences, and technology and are proud to host this exciting congress. So we invite you to attend this scientific gathering in our vibrant city-state.
This conference jointly organized between the Human Genome Organization and the International Association of Breast Cancer Research focuses on the intersection of Genomics , Biology, and Breast Cancer Treatment. This focus and the partnership of the two organizations show how the genomic technologies, when combined with our knowledge of breast cancer biology is beginning to form our strategies for personalized breast cancer therapy. In Singapore, we are working directly at the nexus of these three streams of clinical and basic sciences, and technology and are proud to host this exciting congress. So we invite you to attend this scientific gathering in our vibrant city-state. 
It is our pleasure to invite you to the 27th IABCR-HUGO Genomics, Biology & Breast Cancer Treatment Conference in Singapore. This exciting meeting will be hosted by the Genome Institute of Singapore (GIS) in October 2010. Established over 50 years ago, the IABCR is one of the oldest organisations to advance the exchange of information between basic and clinical breast cancer research, and serves as a platform to promote interactions between Asia-Pac and the western scientific community. This breast cancer meeting will cover topics such as Quantitative Medicine and Clinical Trials, Use of Animal Models, Systems Pharmacology and Genomics and Biomarker Discovery. It will also showcase groundbreaking research of Singapore centres. We hope you will join us in Singapore.